Current participation in another therapeutic clinical trial
Current treatment or participation on another therapeutic clinical trial
Current treatment on another therapeutic clinical trial
Concurrent participation in another therapeutic clinical trial
Concurrent enrollment in another therapeutic clinical trial.
Concurrent participation in another therapeutic clinical trial.
Is participating in another therapeutic clinical trial
Enrollment into another therapeutic clinical trial.
Concurrent participation in another therapeutic or imaging clinical trial.
Concurrent participation in another therapeutic treatment trial
Current treatment on another therapeutic clinical trial
Concurrent participation in another therapeutic clinical trial.
CAPMATINIB EXCLUSION CRITERIA: Current participation in another therapeutic clinical trial
CERITINIB EXCLUSION CRITERIA: Current participation in another therapeutic clinical trial
REGORAFENIB EXCLUSION CRITERIA: Current participation in another therapeutic clinical trial
ENTRECTINIB EXCLUSION CRITERIA: Current participation in another therapeutic clinical trial
Current treatment on another clinical trial
Current treatment on another therapeutic clinical trial
Concurrent participation in another therapeutic clinical trial
Concurrent treatment with any other anti-neoplastic drug or concurrent participation in another therapeutic clinical trial
Concurrent treatment with any other anti-neoplastic drug or concurrent participation in another therapeutic clinical trial
Current treatment on another clinical trial; participation in non-therapeutic clinical trials is permissible
Current treatment on another therapeutic clinical trial
Current participation in another therapeutic clinical trial.
Major surgical intervention or participation in a therapeutic clinical trial within  days from Day  of the first dose of MSCA
Current treatment on another therapeutic clinical trial
Concurrent participation in another therapeutic clinical trial.
Treatment on another therapeutic clinical trial within  weeks of enrollment in this trial
Current treatment on another therapeutic clinical trial
Current treatment on another clinical trial
concurrent treatment on another therapeutic clinical trial
Concurrent participation in another therapeutic clinical trial
Concurrent participation in another therapeutic clinical trial;
Concurrent participation in another therapeutic clinical trial
Received last dose of study drug on another therapeutic clinical trial within  days prior to randomization
Current treatment on another therapeutic clinical trial
Received last dose of study drug on another therapeutic clinical trial within  days prior to enrollment
Participation in a therapeutic research trial within the past three months
Patient is enrolled in any other therapeutic clinical protocol or investigational trial
Actively participating in another therapeutic clinical trial
Patient is enrolled in any other therapeutic clinical protocol or investigational trial
Concurrent participation in another therapeutic treatment trial.
Concurrent participation in another therapeutic clinical trial.
current treatment in another clinical trial
Enrolled on a therapeutic or supportive care clinical trial
Participation in a therapeutic clinical trial
Participants must not have been asked previously to participate in another therapeutic cancer clinical trial
Current enrollment in a therapeutic clinical trial
Intention to enroll in a blinded therapeutic clinical trial
Current treatment on another therapeutic clinical trial
